OPTIMIZERx provides unique platforms to help patients better afford and comply to their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company's patient support website, www.OPTIMIZERx.com, and its permanent subscriber base, continue to grow each month and is quickly becoming the preferred way to access branded prescription savings and support programs.

Additionally, OPTIMIZERx has developed OFFERx(TM) and ADHERxE(TM) to allow a more streamlined, effective way to create, promote and manage new trial or co-pay programs on behalf of brand-name pharmaceuticals and health care products.

OPTIMIZERx website helps patient reduce rising prescription drug co-pay costs.

OptimizeRx Corporation
407 Sixth Street
Rochester, MI 48307
United States - Map
Phone: 248-651-6558
Fax: 248-453-5529

OPTIMIZERx Corporation Official Website

OPTIMIZERx Moves to the OTC Bulletin Board (Friday, Nov 13th, 2009)
WebMD Co-Founder Aims to Change the Way Drug Samples Are Dispensed With SampleMD (Monday, September 21st, 2009)

Safe Harbor disclaimer: Certain statements contained herein constitute forward-looking statements within the meaning of Section 27Aof the Securities Act and Section 21E of the Exchange Act. Such statements include, without limitation, statements regarding business and financing plans, business trends and future operating revenues and expenses. Although the company believes that the statements are reasonable, it can give no assurance that such expecta- tions will prove to be correct. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate and similar expressions, or which by their nature refer to future events. The company cautions investors that any forward-looking statements made by the company are not guarantees of future performance, and that the actual results may differ materially from those in the forward-looking statements as a result of vari- ous factors, including but not limited to, the company’s ability to continue its projected growth, or to be able to fully implement its business strategies.

This profile is not without bias, and is a paid release. investingnewsalerts.com has been compensated for dissemination of company information on behalf of a third party. investingnewsalerts.com has been compensated $15,000  for coverage of this stock, by a third party, for services provided including dissemination of company information in this release. investingnewsalerts.com holds no shares of the stock. investingnewsalerts.com may receive shares for extension of its services. Any shares will be disclosed at such time that investingnewsalerts.com is aware of a clients desire to extend the original services. investingnewsalerts.com may have received shares of a company profiled in this release prior to the dissemination of the information in this release. investingnewsalerts.com may immediately sell some or any shares in a profiled company held by investingnewsalerts.com and may have previously sold shares in a profiled company held by investingnewsalerts.com. investingnewsalerts.com's services for a company may cause the company's stock price to increase, in which event investornewsalerts.com would make a profit when it sells its stock in a company. In addition, investingnewsalerts.com's selling of a company's stock may have a negative effect on the market price of the stock.

Got question, found problem? - info@investingnewsalerts.com